Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia pledges Aus$12.5m for chlamydia initiative:

This article was originally published in Clinica

Executive Summary

Australia will spend Aus$12.5m (US$9.6m) on an initiative to combat chlamydia. The funds, to be spread over four years, will be spent on a pilot testing programme and on improved surveillance and awareness programmes for potential sufferers. The testing programme will target women aged 18-30. The initiative is in response to public health concerns expressed in the First National Sexually Transmissible Infections Strategy, which was launched this week and will run until 2008, concurrently with the national HIV/AIDS and hepatitis C strategies. In 2004, 36,000 cases of chlamydia were reported in Australia - a 20% rise on 2003.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT055626

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel